Resultados globales: 97 registros encontrados en 0.01 segundos.
Artículos, Encontrados 40 registros
Documentos de investigación, Encontrados 31 registros
Materiales académicos, Encontrados 26 registros
Artículos Encontrados 40 registros  1 - 10siguientefinal  ir al registro:
1.
15 p, 2.5 MB CDK5RAP3, a New BRCA2 Partner That Regulates DNA Repair, Is Associated with Breast Cancer Survival / Minguillón Pedreño, Jordi (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Ramírez de Haro, Ma. José (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Rovirosa Mulet, Llorenç (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Bustamante-Madrid, Pilar (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Camps-Fajol, Cristina (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; de Garibay, Gorka Ruiz (Institut Català d'Oncologia) ; Shimelis, Hermela (Mayo Clinic) ; Montanuy Escribano, Helena (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Pujol, Roser (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Hernandez, Gonzalo (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Bogliolo, Massimo (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Castillo, Pau (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Soucy, Penny (Centre Hospitalier Universitaire de Québec Research Center and Laval University) ; Martrat, Griselda (Institut Català d'Oncologia) ; Gómez Moruno, Antonio (Institut d'Investigació Biomèdica de Bellvitge) ; Cuadras, Daniel (Institut Català d'Oncologia) ; García, Maria J. (Centro Nacional de Investigaciones Oncológicas Carlos III (Espanya)) ; Gayarre, Javier (Centro Nacional de Investigaciones Oncológicas Carlos III (Espanya)) ; Lázaro Garcia, Conxi (Institut Català d'Oncologia) ; Benítez, Javier (Centro Nacional de Investigaciones Oncológicas Carlos III (Espanya)) ; Couch, Fergus J. (Mayo Clinic) ; Pujana, Miquel Ángel (Institut Català d'Oncologia) ; Surrallés i Calonge, Jordi (Institut d'Investigació Biomèdica Sant Pau)
BRCA2 is essential for homologous recombination DNA repair. BRCA2 mutations lead to genome instability and increased risk of breast and ovarian cancer. Similarly, mutations in BRCA2-interacting proteins are also known to modulate sensitivity to DNA damage agents and are established cancer risk factors. [...]
2022 - 10.3390/cancers14020353
Cancers, Vol. 14 Núm. 2 (1-2 2022) , p. 353  
2.
9 p, 1.5 MB Limited detection of human polyomaviruses in Fanconi anemia related squamous cell carcinoma / Toptan, Tuna (University of Pittsburgh, Pennsylvania, United States of America) ; Brusadelli, Marion G. (Cincinnati Children's Hospital Medical Center, Ohio, United States of America) ; Turpin, Brian (Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States of America) ; Witte, David P. (Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States of America) ; Surrallés i Calonge, Jordi (Institut d'Investigació Biomèdica Sant Pau) ; Velleuer, Eunike (Hospital Neuwerk Maria von den Aposteln, Mönchengladbach, Germany) ; Schramm, Martin (Heinrich Heine University, Düsseldorf, Germany) ; Dietrich, Ralf (Deutsche Fanconi-Anämie-Hilfe e.V., Unna-Siddinghausen, Germany) ; Brakenhoff, Ruud H. (Vrije Universiteit Amsterdam, The Netherlands) ; Moore, Patrick S. (University of Pittsburgh, Pennsylvania, United States of America) ; Chang, Yuan (University of Pittsburgh, Pennsylvania, United States of America) ; Wells, Susanne I. (C Cincinnati Children's Hospital Medical Center, Ohio, United States of America) ; Universitat Autònoma de Barcelona
Fanconi anemia is a rare genome instability disorder with extreme susceptibility to squamous cell carcinoma of the head and neck and anogenital tract. In patients with this inherited disorder, the risk of head and neck cancer is 800-fold higher than in the general population, a finding which might suggest a viral etiology. [...]
2018 - 10.1371/journal.pone.0209235
PloS one, Vol. 13 (december 2018)  
3.
9 p, 1.5 MB High content drug screening for Fanconi anemia therapeutics / Montanuy, Helena (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Camps-Fajol, Cristina (Institut d'Investigació Biomèdica Sant Pau) ; Carreras-Puigvert, Jordi (Centro de Investigación Biomédica en Red de Enfermedades Raras) ; Häggblad, Maria (Karolinska Institutet (Estocolm, Suècia)) ; Lundgren, Bo (Stockholm University) ; Aza-Carmona, Miriam (Centro de Investigación Biomédica en Red de Enfermedades Raras) ; Helleday, Thomas (Karolinska Institutet Biology, Science for Life Laboratory, Department of Molecular Biochemistry and Biophysics) ; Minguillón Pedreño, Jordi (Institut d'Investigació Biomèdica Sant Pau) ; Surrallés i Calonge, Jordi (Institut d'Investigació Biomèdica Sant Pau) ; Universitat Autònoma de Barcelona
Fanconi anemia is a rare disease clinically characterized by malformations, bone marrow failure and an increased risk of solid tumors and hematologic malignancies. The only therapies available are hematopoietic stem cell transplantation for bone marrow failure or leukemia, and surgical resection for solid tumors. [...]
2020 - 10.1186/s13023-020-01437-1
Orphanet Journal of Rare Diseases, Vol. 15 (june 2020)  
4.
14 p, 1.7 MB Generating new fanca-deficient hnscc cell lines by genomic editing recapitulates the cellular phenotypes of fanconi anemia / Errazquin, Ricardo (Molecular Oncology Unit. CIEMAT) ; Sieiro, Esther (Molecular Oncology Unit. CIEMAT) ; Moreno Sánchez, Pilar (Molecular Oncology Unit. CIEMAT) ; Ramírez de Haro, Ma. José (Institut d'Investigació Biomèdica Sant Pau) ; Lorz, Corina (Centro de Investigación Biomédica en Red de Cáncer) ; Peral, Jorge (Molecular Oncology Unit. CIEMAT) ; Ortiz, Jessica (Molecular Oncology Unit. CIEMAT) ; Casado, José Antonio (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ; Roman-Rodriguez, Francisco J. (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ; Hanenberg, Helmut (Heinrich Heine University) ; Río, Paula (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ; Surrallés i Calonge, Jordi (Institut d'Investigació Biomèdica Sant Pau) ; Segrelles, Carmen (Centro de Investigación Biomédica en Red de Cáncer) ; Garcia-Escudero, Ramon (Centro de Investigación Biomédica en Red de Cáncer) ; Universitat Autònoma de Barcelona
Fanconi anemia (FA) patients have an exacerbated risk of head and neck squamous cell carcinoma (HNSCC). Treatment is challenging as FA patients display enhanced toxicity to standard treatments, including radio/chemotherapy. [...]
2021 - 10.3390/genes12040548
Genes, Vol. 12 Núm. 4 (april 2021) , p. 548  
5.
22 p, 999.9 KB CRISPR Screens in Synthetic Lethality and Combinatorial Therapies for Cancer / Castells-Roca, Laia (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Tejero, Eudald (Institut d'Investigació Biomèdica Sant Pau) ; Rodríguez-Santiago, Benjamín (Institut d'Investigació Biomèdica Sant Pau) ; Surrallés i Calonge, Jordi (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia)
Cancer is a complex disease resulting from the accumulation of genetic dysfunctions. Tumor heterogeneity causes the molecular variety that divergently controls responses to chemotherapy, leading to the recurrent problem of cancer reappearance. [...]
2021 - 10.3390/cancers13071591
Cancers, Vol. 13 Núm. 7 (2021) , p. 1591  
6.
8 p, 885.9 KB Next-generation Sequencing in Bone Marrow Failure Syndromes and Isolated Cytopenias : Experience of the Spanish Network on Bone Marrow Failure Syndromes / Gálvez, Eva (Centro de Investigación Biomédica en Red de Enfermedades Raras) ; Vallespín, Elena (Instituto de Investigación Sanitaria del Hospital Universitario La Paz) ; Arias-Salgado, Elena G. (Instituto de Investigación Sanitaria del Hospital Universitario La Paz) ; Sánchez-Valdepeñas, Carmen (Hospital Infantil Universitario Niño Jesús (Madrid)) ; Giménez, Yari (Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (Madrid)) ; Navarro, Susana (Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (Madrid)) ; Río, Paula (Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (Madrid)) ; Bogliolo, Massimo (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Pujol, Roser (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Peiró, Montserrat (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Nevado, Julián (ITHACA, European Reference Network) ; Zubicaray, Josune (Hospital Infantil Universitario Niño Jesús (Madrid)) ; Sebastián, Elena (Hospital Infantil Universitario Niño Jesús (Madrid)) ; Catalá, Albert (Sociedad Española de Hematología y Oncología-SEHOP. Grupo insuficiencias medulares) ; Beléndez, Cristina (Hospital General Universitario Gregorio Marañón) ; Díaz de Heredia, Cristina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Galera, Ana (Hospital Universitario Virgen de la Arrixaca (Múrcia)) ; Badell Serra, Isabel (Institut d'Investigació Biomèdica Sant Pau) ; Madero, Luis (Hospital Infantil Universitario Niño Jesús (Madrid)) ; Perona, Rosario (Instituto de Investigación Sanitaria del Hospital Universitario La Paz) ; Sastre, Leandro (Instituto de Investigación Sanitaria del Hospital Universitario La Paz) ; Surrallés i Calonge, Jordi (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Bueren, Juan (Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (Madrid)) ; Lapunzina, Pablo (ITHACA, European Reference Network) ; Sevilla, Julián (Sociedad Española de Hematología y Oncología-SEHOP. Grupo insuficiencias medulares)
Inherited bone marrow failure syndromes (IBMFSs) are a group of congenital rare diseases characterized by bone marrow failure, congenital anomalies, high genetic heterogeneity, and predisposition to cancer. [...]
2021 - 10.1097/HS9.0000000000000539
HemaSphere, Vol. 5 (march 2021)  
7.
12 p, 2.2 MB FANCA Gene Mutations in North African Fanconi Anemia Patients / Ben Haj Ali, Abir (Institut Pasteur de Tunis. Laboratory of Biomedical Genomics and Oncogenetics) ; Messaoud, Olfa (Institut Pasteur de Tunis. Laboratory of Biomedical Genomics and Oncogenetics) ; Elouej, Sahar (INSERM, MMG, UMR 1251, Aix Marseille University) ; Talmoudi, Faten (Institut Pasteur de Tunis. Laboratory of Biomedical Genomics and Oncogenetics) ; Ayed, Wiem (Institut Pasteur de Tunis. Laboratory of Biomedical Genomics and Oncogenetics) ; Mellouli, Fethi (Department of Peadiatric Immuno-Haematology, National Bone Marrow Transplantation) ; Ouederni, Monia (Department of Peadiatric Immuno-Haematology, National Bone Marrow Transplantation) ; Hadiji, Sondes (Haematology Department, Hedi Chaker Hospital, University of Sfax) ; De Sandre-Giovannoli, Annachiara (INSERM, MMG, UMR 1251, Aix Marseille University) ; Delague, Valérie (INSERM, MMG, UMR 1251, Aix Marseille University) ; Lévy, Nicolas (INSERM, MMG, UMR 1251, Aix Marseille University) ; Bogliolo, Massimo (Institut d'Investigació Biomèdica Sant Pau) ; Surrallés i Calonge, Jordi (Institut d'Investigació Biomèdica Sant Pau) ; Abdelhak, Sonia (Institut Pasteur de Tunis. Laboratory of Biomedical Genomics and Oncogenetics) ; Amouri, Ahlem (Institut Pasteur de Tunis. Laboratory of Biomedical Genomics and Oncogenetics) ; Universitat Autònoma de Barcelona
Populations in North Africa (NA) are characterized by a high rate of consanguinity. Consequently, the proportion of founder mutations might be higher than expected and could be a major cause for the high prevalence of recessive genetic disorders like Fanconi anemia (FA). [...]
2021 - 10.3389/fgene.2021.610050
Frontiers in genetics, Vol. 12 (february 2021)  
8.
14 p, 1.9 MB The FANCM :p.Arg658* truncating variant is associated with risk of triple-negative breast cancer / Figlioli, Gisella (The FIRC Institute for Molecular Oncology) ; Bogliolo, Massimo (Institut d'Investigació Biomèdica Sant Pau) ; Catucci, Irene (The FIRC Institute for Molecular Oncology) ; Caleca, Laura (Istituto Nazionale dei Tumori, Department of Research) ; Viz Lasheras, Sandra (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Pujol, Roser (Institut d'Investigació Biomèdica Sant Pau) ; Kiiski, Johanna I. (University of Helsinki, Department of Obstetrics and Gynecology) ; Muranen, Taru A. (University of Helsinki, Department of Obstetrics and Gynecology) ; Barnes, Daniel R. (University of Cambridge, Department of Public Health and Primary Care) ; Dennis, Joe (University of Cambridge, Department of Public Health and Primary Care) ; Michailidou, Kyriaki (The Cyprus Institute of Neurology & Genetics, Department of Electron Microscopy) ; Bolla, Manjeet K. (University of Cambridge, Department of Public Health and Primary Care) ; Leslie, Goska (University of Cambridge, Department of Public Health and Primary Care) ; Aalfs, Cora M. (Amsterdam UMC, Department of Clinical Genetics) ; Adank, Muriel A. (The Netherlands Cancer Institute (NKI) (Netherlands)) ; Adlard, Julian (Chapel Allerton Hospital) ; Agata, Simona (Veneto Institute of Oncology) ; Cadoo, Karen (Memorial Sloan Kettering Cancer Center) ; Agnarsson, Bjarni A. (University of Iceland, School of Medicine) ; Ahearn, Thomas (National Cancer Institute) ; Aittomäki, Kristiina (University of Helsinki, Department of Clinical Genetics) ; Ambrosone, Christine B. (Roswell Park Cancer Institute) ; Andrews, Lesley (Nelune Comprehensive Cancer Care Centre) ; Anton-Culver, Hoda (University of California Irvine, Department of Epidemiology) ; Antonenkova, Natalia N. (N.N. Alexandrov Research Institute of Oncology and Medical Radiology) ; Arndt, Volker (German Cancer Research Center) ; Arnold, Norbert (University Hospital of Schleswig-Holstein, Department of Gynaecology and Obstetrics) ; Aronson, Kristan J. (Queen's University, Department of Public Health Sciences) ; Arun, Banu K. (University of Texas, Department of Breast Medical Oncology) ; Asseryanis, Ella (Medical University of Vienna, Dept of OB/GYN and Comprehensive Cancer Center) ; Auber, Bernd (Institute of Human Genetics) ; Auvinen, Päivi (University of Eastern Finland, Translational Cancer Research Area) ; Azzollini, Jacopo (Fondazione Istituto Nazionale dei Tumori di Milano, Department of Medical Oncology and Hematology) ; Balmaña Gelpí, Judith (Hospital Universitari Vall d'Hebron) ; Barkardottir, Rosa B. (University of Iceland) ; Barrowdale, Daniel (University of Cambridge, Department of Public Health and Primary Care) ; Barwell, Julian (University Hospitals of Leicester) ; Beane Freeman, Laura E. (National Cancer Institute) ; Beauparlant, Charles Joly (Centre Hospitalier Universitaire de Québec - Université Laval) ; Beckmann, Matthias W. (Friedrich-Alexander-University Erlangen-Nuremberg, Department of Gynecology and Obstetrics) ; Behrens, Sabine (German Cancer Research Center) ; Benitez, Javier (Centro Nacional de Investigaciones Oncológicas) ; Berger, Raanan (Chaim Sheba Medical Center. The Institute of Oncology) ; Bermisheva, Marina (Institute of Biochemistry and Genetics) ; Blanco, Amie M. (University of California San Francisco) ; Blomqvist, Carl (Örebro University Hospital, Department of Oncology) ; Bogdanova, Natalia V. (Hannover Medical School) ; Bojesen, Anders (Aarhus University Hospital (Aarhus, Dinamarca)) ; Bojesen, Stig E. (University of Copenhagen) ; Bonanni, Bernardo (IEO, European Institute of Oncology) ; Borg, Ake (Lund University and Skåne University Hospital, Department of Oncology) ; Brady, Angela F. (London North West University Hospitals) ; Brauch, Hiltrud (German Cancer Research Center) ; Brenner, Hermann (German Cancer Research Center) ; Brüning, Thomas (Institute of the Ruhr University Bochum) ; Burwinkel, Barbara (University of Heidelberg) ; Buys, Saundra S. (Huntsman Cancer Institute, Department of Medicine) ; Caldés, Trinidad (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos) ; Caliebe, Almuth (University Hospital of Schleswig-Holstein) ; Caligo, Maria A. (University Hospital of Pisa (Pisa, Itàlia)) ; Campa, Daniele (University of Pisa, Department of Biology) ; Campbell, Ian G. (The University of Melbourne, Department of Oncology) ; Canzian, Federico (German Cancer Research Center) ; Castelao, Jose E. (Instituto de Investigación Sanitaria Galicia Sur) ; Chang-Claude, Jenny (University Medical Center Hamburg-Eppendorf) ; Chanock, Stephen J. (National Cancer Institute) ; Claes, Kathleen B. M. (Ghent University, Centre for Medical Genetics) ; Clarke, Christine L. (University of Sydney, Westmead Institute for Medical Research) ; Collavoli, Anita (University and University Hospital of Pisa, Department of Laboratory Medicine) ; Conner, Thomas A. (Huntsman Cancer Institute) ; Cox, David G. (Cancer Research Center of Lyon) ; Cybulski, Cezary (Pomeranian Medical University, Department of Genetics and Pathology) ; Czene, Kamila (Karolinska Institutet (Estocolm, Suècia). Department of Medical Epidemiology and Biostatistics) ; Daly, Mary B. (Fox Chase Cancer Center, Department of Clinical Genetics) ; de la Hoya, Miguel (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos) ; Devilee, Peter (Leiden University Medical Center, Department of Human Genetics) ; Diez, Orland (Hospital Universitari Vall d'Hebron) ; Ding, Yuan Chun (Beckman Research Institute of City of Hope, Department of Population Sciences) ; Dite, Gillian S. (The University of Melbourne) ; Ditsch, Nina (Ludwig Maximilian University of Munich, Department of Gynecology and Obstetrics) ; Domchek, Susan M. (Perelman School of Medicine at the University of Pennsylvania, Department of Medicine) ; Dorfling, Cecilia M. (University of Pretoria, Department of Genetics) ; dos-Santos-Silva, Isabel (London School of Hygiene and Tropical Medicine, Department of Non-Communicable Disease Epidemiology) ; Durda, Katarzyna (Pomeranian Medical University, Department of Genetics and Pathology) ; Dwek, Miriam (University of Westminster, Department of Biomedical Sciences) ; Eccles, Diana M. (University of Southampton, Cancer Sciences Academic Unit) ; Ekici, Arif B. (Friedrich-Alexander University Erlangen-Nuremberg) ; Eliassen, A. Heather (Harvard T.H. Chan School of Public Health, Department of Epidemiology) ; Ellberg, Carolina (Lund University, Department of Cancer Epidemiology) ; Eriksson, Mikael (Karolinska Institutet (Estocolm, Suècia). Department of Medical Epidemiology and Biostatistics) ; Evans, D. Gareth (Manchester University NHS Foundation Trust) ; Fasching, Peter A. (University of California at Los Angeles, Department of Medicine Division of Hematology and Oncology) ; Figueroa, Jonine (Cancer Research UK Edinburgh Centre) ; Flyger, Henrik (Copenhagen University Hospital) ; Foulkes, William D. (McGill University, Departments of Human Genetics and Oncology) ; Friebel, Tara M. (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Friedman, Eitan (Tel Aviv University) ; Gabrielson, Marike (Karolinska Institutet (Estocolm, Suècia). Department of Medical Epidemiology and Biostatistics) ; Gaddam, Pragna (Memorial Sloan-Kettering Cancer Center (Nova York, Estats Units d'Amèrica)) ; Gago-Dominguez, Manuela (University of California San Diego) ; Gao, Chi (Harvard T.H. Chan School of Public Health (Boston, Estats Units d'Amèrica)) ; Gapstur, Susan M. (American Cancer Society) ; Garber, Judy (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; García-Closas, Montserrat (National Cancer Institute) ; García-Sáenz, José A. (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos) ; Gaudet, Mia M. (American Cancer Society) ; Gayther, Simon A. (Cedars Sinai Heart Institute) ; Giles, Graham G. (Monash University, Department of Epidemiology and Preventive Medicine) ; Glendon, Gord (Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital) ; Godwin, Andrew K. (Kansas University Medical Center, Department of Pathology and Laboratory Medicine) ; Goldberg, Mark S. (McGill University) ; Goldgar, David E. (University of Utah School of Medicine, Department of Dermatology) ; Guénel, Pascal (University Paris-Sud, University Paris-Saclay) ; Gutierrez-Barrera, Angelica M. (University of Texas, Department of Breast Medical Oncology and Clinical Genetics Program) ; Haeberle, Lothar (University Hospital Erlangen) ; Haiman, Christopher A. (University of Southern California, Department of Preventive Medicine) ; Håkansson, Niclas (Karolinska Institutet, Institute of Environmental Medicine) ; Hall, Per (Södersjukhuset, Department of Oncology) ; Hamann, Ute (German Cancer Research Center) ; Harrington, Patricia A. (University of Cambridge, Department of Oncology) ; Hein, Alexander (University Hospital Erlangen) ; Heyworth, Jane (The University of Western Australia) ; Hillemanns, Peter (Hannover Medical School, Gynaecology Research Unit) ; Hollestelle, Antoinette (Erasmus MC Cancer Institute) ; Hopper, John L. (The University of Melbourne) ; Hosgood, H. Dean (Albert Einstein College of Medicine) ; Howell, Anthony (University of Manchester, Division of Cancer Sciences) ; Hu, Chunling (Mayo Clinic, Department of Laboratory Medicine and Pathology) ; Hulick, Peter J. (The University of Chicago Pritzker School of Medicine) ; Hunter, David J. (University of Oxford) ; Imyanitov, Evgeny N. (N.N. Petrov Institute of Oncology) ; Isaacs, Claudine (Georgetown University) ; Jakimovska, Milena (Macedonian Academy of Sciences and Arts) ; Jakubowska, Anna (Pomeranian Medical University) ; James, Paul (Peter MacCallum Cancer Center) ; Janavicius, Ramunas (State Research Institute Innovative Medicine Center) ; Janni, Wolfgang (University Hospital of Ulm (Alemanya)) ; John, Esther M. (Stanford University School of Medicine, Department of Medicine) ; Jones, Michael E. (The Institute of Cancer Research) ; Jung, Audrey (German Cancer Research Center) ; Kaaks, Rudolf (German Cancer Research Center) ; Karlan, Beth Y. (Cedars Sinai Heart Institute) ; Khusnutdinova, Elza (Bashkir State Medical University, Department of Medical Genetics) ; Kitahara, Cari M. (National Cancer Institute) ; Konstantopoulou, Irene (National Centre for Scientific Research 'Demokritos') ; Koutros, Stella (National Cancer Institute) ; Kraft, Peter (Harvard T.H. Chan School of Public Health (Boston, Estats Units d'Amèrica)) ; Lambrechts, Diether (University of Leuven, Department of Human Genetics) ; Lazaro, Conxi (Institut d'Investigació Biomèdica de Bellvitge) ; Le Marchand, Loic (University of Hawaii Cancer Center, Epidemiology Program) ; Lester, Jenny (Cedars Sinai Heart Institute) ; Lesueur, Fabienne (Mines ParisTech) ; Lilyquist, Jenna (Mayo Clinic, Department of Health Sciences Research) ; Loud, Jennifer T. (National Cancer Institute, Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics) ; Lu, Karen H. (University of Texas MD Anderson Cancer Center, Department of Gynecologic Oncology) ; Luben, Robert N. (University of Cambridge, Department of Public Health and Primary Care) ; Lubinski, Jan (Pomeranian Medical University, Department of Genetics and Pathology) ; Mannermaa, Arto (Kuopio University Hospital, Imaging Center, Department of Clinical Pathology) ; Manoochehri, Mehdi (German Cancer Research Center) ; Manoukian, Siranoush (Istituto Nazionale dei Tumori di Milano) ; Margolin, Sara (Karolinska Institutet, Department of Clinical Science and Education) ; Martens, John W. M. (Erasmus MC Cancer Institute) ; Maurer, Tabea (University Medical Center Hamburg-Eppendorf) ; Mavroudis, Dimitrios (University Hospital of Heraklion, Department of Medical Oncology) ; Mebirouk, Noura (Mines ParisTech) ; Meindl, Alfons (Ludwig Maximilian University of Munich, Department of Gynecology and Obstetrics) ; Menon, Usha (University College London) ; Miller, Austin (Roswell Park Cancer Institute) ; Montagna, Marco (Veneto Institute of Oncology) ; Nathanson, Katherine L. (University of Pennsylvania, Department of Medicine) ; Neuhausen, Susan L. (Beckman Research Institute of City of Hope, Department of Population Sciences) ; Newman, William G. (Manchester University NHS Foundation Trust) ; Nguyen-Dumont, Tu (The University of Melbourne, Department of Clinical Pathology) ; Nielsen, Finn Cilius (Copenhagen University Hospital, Center for Genomic Medicine) ; Nielsen, Sarah (The University of Chicago, Center for Clinical Cancer Genetics) ; Nikitina-Zake, Liene (Latvian Biomedical Research and Study Centre) ; Offit, Kenneth (Memorial Sloan-Kettering Cancer Center, Clinical Genetics Service, Department of Medicine) ; Olah, Edith (National Institute of Oncology, Department of Molecular Genetics) ; Olopade, Olufunmilayo I. (The University of Chicago) ; Olshan, Andrew F. (University of North Carolina at Chapel Hill, Department of Epidemiology) ; Olson, Janet E. (Mayo Clinic, Department of Health Sciences Research) ; Olsson, Håkan (Lund University, Department of Cancer Epidemiology, Clinical Sciences) ; Osorio, Ana (Spanish Network on Rare Diseases) ; Ottini, Laura (University La Sapienza, Department of Molecular Medicine) ; Peissel, Bernard (Istituto Nazionale dei Tumori di Milano) ; Peixoto, Ana (Portuguese Oncology Institute, Department of Genetics) ; Peto, Julian (London School of Hygiene and Tropical Medicine, Department of Non-Communicable Disease Epidemiology) ; Plaseska-Karanfilska, Dijana (Macedonian Academy of Sciences and Arts) ; Pocza, Timea (National Institute of Oncology, Department of Molecular Genetics) ; Presneau, Nadege (University of Westminster, Department of Biomedical Sciences) ; Pujana, Miquel Angel (Institut d'Investigació Biomèdica de Bellvitge) ; Punie, Kevin (University Hospitals Leuven (Bèlgica)) ; Rack, Brigitte (University Hospital of Ulm (Alemanya)) ; Rantala, Johanna (Karolinska Institutet, Clinical Genetics) ; Rashid, Muhammad U. (Shaukat Khanum Memorial Cancer Hospital and Research Centre, Department of Basic Sciences) ; Rau-Murthy, Rohini (Memorial Sloan-Kettering Cancer Center, Department of Medicine) ; Rennert, Gad (Clalit National Cancer Control Center) ; Lejbkowicz, Flavio (Clalit National Cancer Control Center) ; Rhenius, Valerie (University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Oncology) ; Romero, Atocha (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Rookus, Matti A. (The Netherlands Cancer Institute, Department of Epidemiology) ; Ross, Eric A. (Fox Chase Cancer Center) ; Rossing, Maria (Copenhagen University Hospital) ; Rudaitis, Vilius (Vilnius University, Institute of Clinical Medicine) ; Ruebner, Matthias (University Hospital Erlangen. Friedrich-Alexander University Erlangen-Nuremberg, Department of Gynaecology and Obstetrics) ; Saloustros, Emmanouil (University Hospital of Larissa, Department of Oncology) ; Sanden, Kristin (University of Wisconsin, Cancer Center at ProHealth Care) ; Santamariña, Marta (Instituto de Investigación Sanitaria de Santiago (IDIS)) ; Scheuner, Maren T. (University of California San Francisco, Cancer Genetics and Prevention Program) ; Schmutzler, Rita K. (University of Cologne, Center for Molecular Medicine Cologne) ; Schneider, Michael (University Hospital Erlangen) ; Scott, Christopher (Mayo Clinic, Department of Health Sciences Research) ; Senter, Leigha (The Ohio State University, Department of Internal Medicine) ; Shah, Mitul (University of Cambridge, Department of Oncology) ; Sharma, Priyanka (University of Kansas Medical Center, Department of Internal Medicine) ; Shu, Xiao-Ou (Vanderbilt University School of Medicine, Department of Medicine) ; Simard, Jacques (Université Laval) ; Singer, Christian F. (Medical University of Vienna) ; Sohn, Christof (University of Heidelberg) ; Soucy, Penny (Université Laval) ; Southey, Melissa C. (The University of Melbourne, Department of Clinical Pathology) ; Spinelli, John J. (University of British Columbia, School of Population and Public Health) ; Steele, Linda (Beckman Research Institute of City of Hope, Department of Population Sciences) ; Stoppa-Lyonnet, Dominique (Université Paris Descartes) ; Tapper, William J. (University of Southampton) ; Teixeira, Manuel R. (University of Porto) ; Terry, Mary Beth (Columbia University, Department of Epidemiology) ; Thomassen, Mads (Odense University Hospital (Dinamarca)) ; Thompson, Jennifer (NorthShore University HealthSystem, Center for Medical Genetics) ; Thull, Darcy L. (University of Pittsburgh School of Medicine, Department of Medicine) ; Tischkowitz, Marc (University of Cambridge, Department of Medical Genetics) ; Tollenaar, Rob A.E.M. (Leiden University Medical Center, Department of Surgery) ; Torres, Diana (Pontificia Universidad Javeriana) ; Troester, Melissa A. (University of North Carolina at Chapel Hill) ; Truong, Thérèse (University Paris-Sud) ; Tung, Nadine (Beth Israel Deaconess Medical Center, Department of Medical Oncology) ; Untch, Michael (Helios Clinics Berlin-Buch, Department of Gynecology and Obstetrics) ; Vachon, Celine M. (Mayo Clinic, Department of Health Sciences Research) ; van Rensburg, Elizabeth J. (University of Pretoria, Department of Genetics) ; van Veen, Elke M. (Manchester University NHS Foundation Trust) ; Vega, Ana (Instituto de Investigación Sanitaria de Santiago (IDIS)) ; Viel, Alessandra (Centro di Riferimento Oncologico di Aviano) ; Wappenschmidt, Barbara (University of Cologne, Center for Molecular Medicine Cologne) ; Weitzel, Jeffrey N. (City of Hope, Clinical Cancer Genetics) ; Wendt, Camilla (Karolinska Institutet (Estocolm, Suècia)) ; Wieme, Greet (Ghent University, Centre for Medical Genetics) ; Wolk, Alicja (Uppsala University, Department of Surgical Sciences) ; Yang, Xiaohong R. (National Cancer Institute) ; Zheng, Wei (Vanderbilt University School of Medicine) ; Ziogas, Argyrios (University of California Irvine, Department of Epidemiology) ; Zorn, Kristin K. (University of Pittsburgh School of Medicine) ; Dunning, Alison M. (University of Cambridge, Department of Oncology) ; Lush, Michael (University of Cambridge, Department of Public Health and Primary Care) ; Wang, Qin (University of Cambridge, Department of Public Health and Primary Care) ; McGuffog, Lesley (University of Cambridge, Department of Public Health and Primary Care) ; Parsons, Michael T. (QIMR Berghofer Medical Research Institute, Department of Genetics and Computational Biology) ; Pharoah, Paul D. P. (University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Oncology) ; Fostira, Florentia (National Centre for Scientific Research 'Demokritos') ; Toland, Amanda E. (The Ohio State University, Department of Cancer Biology and Genetics) ; Andrulis, Irene L. (University of Toronto, Department of Molecular Genetics) ; Ramus, Susan J. (The Kinghorn Cancer Centre, Garvan Institute of Medical Research) ; Swerdlow, Anthony J. (The Institute of Cancer Research) ; Greene, Mark H. (National Cancer Institute, Clinical Genetics Branch) ; Chung, Wendy K. (Columbia University, Departments of Pediatrics and Medicine) ; Milne, Roger L. (Monash University) ; Chenevix-Trench, Georgia (QIMR Berghofer Medical Research Institute, Department of Genetics and Computational Biology) ; Dörk, Thilo (Hannover Medical School) ; Schmidt, Marjanka K. (The Netherlands Cancer Institute (NKI) (Netherlands)) ; Easton, Douglas F. (University of Cambridge, Department of Oncology) ; Radice, Paolo (Istituto Nazionale dei Tumori) ; Hahnen, Eric (University of Cologne) ; Antoniou, Antonis C. (University of Cambridge, Department of Public Health and Primary Care) ; Couch, Fergus J. (Mayo Clinic, Department of Laboratory Medicine and Pathology) ; Nevanlinna, Heli (University of Helsinki, Department of Obstetrics and Gynecology) ; Surrallés i Calonge, Jordi (Institut d'Investigació Biomèdica Sant Pau) ; Peterlongo, Paolo (The FIRC Institute for Molecular Oncology)
Breast cancer is a common disease partially caused by genetic risk factors. Germline pathogenic variants in DNA repair genes BRCA1, BRCA2, PALB2, ATM, and CHEK2 are associated with breast cancer risk. [...]
2019 - 10.1038/s41523-019-0127-5
NPJ breast cancer, Vol. 5 (November 2019) , art. 38  
9.
12 p, 548.1 KB Mosaicism in Fanconi anemia : concise review and evaluation of published cases with focus on clinical course of blood count normalization / Nicoletti, Eileen (Rocket Pharmaceuticals, Inc., New York) ; Rao, Gayatri (Rocket Pharmaceuticals, Inc., New York, NY USA) ; Bueren, Juan A. (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ; Río, Paula (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ; Navarro Ordóñez, Susana (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ; Surrallés i Calonge, Jordi (Institut d'Investigació Biomèdica Sant Pau) ; Choi, Grace (Rocket Pharmaceuticals, Inc., New York) ; Schwartz, Jonathan D. (Rocket Pharmaceuticals, Inc., New York) ; Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia
Fanconi anemia (FA) is a DNA repair disorder resulting from mutations in genes encoding for FA DNA repair complex components and is characterized by variable congenital abnormalities, bone marrow failure (BMF), and high incidences of malignancies. [...]
2020 - 10.1007/s00277-020-03954-2
Annals of Hematology, Vol. 99 (february 2020) , p. 913-924  
10.
9 p, 821.2 KB Biallelic germline BRCA1 mutations in a patient with early onset breast cancer, mild Fanconi anemia-like phenotype, and no chromosome fragility / Keupp, Katharina (Center for Familial Breast and Ovarian Cancer. Center for Integrated Oncology (CIO). University of Cologne) ; Hampp, Stephanie (Department of Obstetrics and Gynecology. Ulm University) ; Hübbel, Annette (Center for Familial Breast and Ovarian Cancer. Center for Integrated Oncology (CIO). University of Cologne) ; Maringa, Monika (Center for Familial Breast and Ovarian Cancer. Center for Integrated Oncology (CIO). University of Cologne) ; Kostezka, Sarah (Department of Obstetrics and Gynecology. Ulm University) ; Rhiem, Kerstin (Center for Familial Breast and Ovarian Cancer. Center for Integrated Oncology (CIO). University of Cologne) ; Waha, Anke (Center for Familial Breast and Ovarian Cancer. Center for Integrated Oncology (CIO). University of Cologne) ; Wappenschmidt, Barbara (Center for Familial Breast and Ovarian Cancer. Center for Integrated Oncology (CIO). University of Cologne) ; Pujol, Roser. (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Surrallés i Calonge, Jordi (Institut d'Investigació Biomèdica Sant Pau) ; Schmutzler, Rita K. (Center for Familial Breast and Ovarian Cancer. Center for Integrated Oncology (CIO). University of Cologne) ; Wiesmüller, Lisa (Department of Obstetrics and Gynecology. Ulm University) ; Hahnen, Eric (Center for Familial Breast and Ovarian Cancer. Center for Integrated Oncology (CIO). University of Cologne)
Background: Biallelic BRCA1 mutations are regarded either embryonically lethal or to cause Fanconi anemia (FA), a genomic instability syndrome characterized by bone marrow failure, developmental abnormalities, and cancer predisposition. [...]
2019 - 10.1002/mgg3.863
Molecular genetics & genomic medicine, Vol. 7 Núm. 9 (january 2019) , p. e863  

Artículos : Encontrados 40 registros   1 - 10siguientefinal  ir al registro:
Documentos de investigación Encontrados 31 registros  1 - 10siguientefinal  ir al registro:
1.
120 p, 1.1 MB Aplicación clínica de los paneles de genes de susceptibilidad al cáncer : caracterización de variantes en genes de riesgo e impacto psicológico / Esteban Marcos, Irene ; Balmaña Gelpí, Judith, dir. ; Surrallés i Calonge, Jordi, dir. ; Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia
Introducción: Los paneles de genes en cáncer hereditario se están incorporando a la práctica clínica. Estos paneles pueden incluir genes asociados a distintos tipos de cáncer y con distintos niveles de riesgo. [...]
Introduction: Hereditary cancer panels are currently being incorporated into clinical practice. These panels can include genes associated with different types of cancer and different levels of risk. [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2019.  
2.
205 p, 6.3 MB Genetic and proteomic study of ERCC4/XPF in DNA repair and human diseases / Marín Vilar, Maria ; Surrallés i Calonge, Jordi, dir. ; Bogliolo, Massimo, dir. ; Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia
Qualsevol canvi en el DNA d'un organisme pot afectar tots els aspectes de la seva vida, fins el punt de comprometre-la. Per tal de superar aquesta situació, les cèl·lules han evolucionat fins adquirir sofisticades maquinàries de reparació del dany causat al DNA. [...]
[Barcelona] : Universitat Autònoma de Barcelona, 2018.  
3.
235 p, 15.9 MB Recerca terapèutica en l'anèmia de Fanconi / Montanuy Escribano, Helena ; Surrallés i Calonge, Jordi, dir. ; Minguillón Pedreño, Jordi, dir. ; Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia
S'estan dedicant molts esforços en trobar una teràpia eficient pel tractament de les principals complicacions en l'anèmia de Fanconi, la fallada del moll de l'os i el càncer. També, hi ha estudis que es centren en la recerca de tractaments crònics per la prevenció de la malaltia. [...]
Much effort is being made on Fanconi anemia therapeutics to treat bone marrow failure and cancer, the most life threatening signs of the disease. There are also studies searching for prevention, with chronic treatment proposals. [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2017.  
4.
214 p, 6.4 MB Secuenciación del exoma en anemia de Fanconi : del diagnóstico al descubrimiento de un nuevo gen / Bogliolo, Massimo (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Surrallés i Calonge, Jordi, dir. (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia
La anemia de Fanconi (AF) es un trastorno genético raro de inestabilidad genómica que se caracteriza por insuficiencia de la médula ósea y predisposición al cáncer. Las 19 proteínas AF conocidas hasta el día de hoy están implicadas en la reparación de los enlaces entrecruzados del ADN (ICL). [...]
Fanconi anemia (FA) is a rare genomic instability disorder characterized by progressive bone marrow failure and predisposition to cancer. 19 FA-associated proteins are involved in the repair of DNA interstrand crosslinks (ICLs). [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2015  
5.
1 p, 172.9 KB Fanconi anemia : an informative webpage on a rare disease / Portabella Navarro, Marc ; Surrallés i Calonge, Jordi, dir. (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2015
Grau en Genètica [833]  
6.
1 p, 1.0 MB Non-BRCA high-penetrance breast cancer susceptibility genes / Otero González, Andrea ; Surrallés i Calonge, Jordi, dir. (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2015
Grau en Genètica [833]  
7.
1 p, 3.1 MB La anemia de Fanconi : divulgative project / Graupera de la Torre, Víctor ; Surrallés i Calonge, Jordi, dir. (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2015
Grau en Genètica [833]  
8.
1 p, 5.2 MB The basis of gene therapy : from the molecule to the treatment / Sanjurjo Sampedro, Miguel ; Surrallés i Calonge, Jordi, dir. (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2013
Grau en Genètica [833]  
9.
129 p, 2.0 MB Significació pronòstica de l'estatus mutacional del gen K-RAS en càncer de còlon. Estudi retrospectiu / Surrallés i Calonge, M.Lluïsa ; Salas Caudevilla, Antonio, dir. ; Surrallés i Calonge, Jordi ; Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia
El càncer colorectal és el tipus de neoplàsia més comuna en els països desenvolupats i representa la segona causa de mort per càncer. Per tant, el coneixement de les bases moleculars implicades en la carcinogènesi poden facilitar el diagnòstic i el tractament del càncer. [...]
Colorectal cancer is one of the most common human malignances and one of the leadingd causes of cancer-related deaths in the development countries. Improvements in the knowledge of cancer biology have led to the development of the best diagnostic and teatment. [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2014  
10.
1 p, 5.6 MB Informative website about Rett syndrome / García G., Rocio ; Surrallés i Calonge, Jordi, dir. (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2014
Grau en Genètica [833]  

Documentos de investigación : Encontrados 31 registros   1 - 10siguientefinal  ir al registro:
Materiales académicos Encontrados 26 registros  1 - 10siguientefinal  ir al registro:
1.
4 p, 72.3 KB Predisposició Genètica al Càncer [42929] / Surrallés i Calonge, Jordi (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Bogliolo, Massimo (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Steigerwald, Daniela ; Hernandez Viedma, Gonzalo ; Universitat Autònoma de Barcelona. Facultat de Biociències
The aim of this module is to dissect the genetic basis of cancer predisposition. We will discuss and perform laboratory experiments to explore the molecular basis of syndromes such as hereditary breast cancer, familiar colon cancer or rare DNA repair syndromes characterized by cancer predisposition such as Xeroderma pigmentosum, Fanconi anemia or Lynch syndromes. [...]
2017-18
Màster Universitari en Genètica Avançada / Advanced Genetics [1156]
2 documentos
2.
4 p, 77.2 KB Genètica del càncer i oncologia [101882] / Armengol Rosell, Gemma (Universitat Autònoma de Barcelona. Departament de Biologia Animal, de Biologia Vegetal i d'Ecologia) ; Caballín, M. R. (María Rosa) (Universitat Autònoma de Barcelona. Departament de Biologia Animal, de Biologia Vegetal i d'Ecologia) ; Miró, Rosa (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Surrallés i Calonge, Jordi (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Hernández Bonilla, Alba (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Universitat Autònoma de Barcelona. Facultat de Biociències
Els objectius de l'assignatura són mostrar com l'adquisició de mutacions somàtiques contribueixen al creixement tumoral i com les variacions genètiques heretades contribueixen a la susceptibilitat al càncer. [...]
2017-18
Grau en Ciències Biomèdiques [832]
3 documentos
3.
4 p, 78.9 KB Diagnòstic genètic molecular [101973] / Surrallés i Calonge, Jordi (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Xamena, N. (Noel) (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Bogliolo, Massimo (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Universitat Autònoma de Barcelona. Facultat de Biociències
Els principals objectius d'aquesta assignatura són: Conèixer i poder descriure les principals tècniques d'anàlisi molecular emprades usualment en el diagnòstic genètic. Seleccionar amb sentit crític les tècniques diagnòstiques més adients en cada cas. [...]
2017-18
Grau en Genètica [833]
3 documentos
4.
4 p, 75.8 KB Genètica del càncer [101972] / Armengol Rosell, Gemma (Universitat Autònoma de Barcelona. Departament de Biologia Animal, de Biologia Vegetal i d'Ecologia) ; Caballín, M. R. (María Rosa) (Universitat Autònoma de Barcelona. Departament de Biologia Animal, de Biologia Vegetal i d'Ecologia) ; Miró, Rosa (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Surrallés i Calonge, Jordi (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Hernández Bonilla, Alba (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Universitat Autònoma de Barcelona. Facultat de Biociències
Els objectius de l'assignatura són mostrar com l'adquisició de mutacions somàtiques contribueixen al creixement tumoral i com les variacións genètiques heredades contribueixen a la susceptibilitat al càncer. [...]
2017-18
Grau en Genètica [833]
3 documentos
5.
4 p, 72.3 KB Predisposició Genètica al Càncer [42929] / Surrallés i Calonge, Jordi (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Universitat Autònoma de Barcelona. Facultat de Biociències
The aim of this module is to dissect the genetic basis of cancer predisposition. We will discuss and perform laboratory experiments to explore the molecular basis of syndromes such as hereditary breast cancer, familiar colon cancer or rare DNA repair syndromes characterized by cancer predisposition such as Xeroderma pigmentosum, Fanconi anemia or Lynch syndromes. [...]
2016-17
Màster Universitari en Genètica Avançada / Advanced Genetics [1156]
2 documentos
6.
4 p, 78.7 KB Diagnòstic genètic molecular [101973] / Surrallés i Calonge, Jordi (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Universitat Autònoma de Barcelona. Facultat de Biociències
Els principals objectius d'aquesta assignatura són: Conèixer i poder descriure les principals tècniques d'anàlisi molecular emprades usualment en el diagnòstic genètic. Seleccionar amb sentit crític les tècniques diagnòstiques més adients en cada cas. [...]
2016-17
Grau en Genètica [833]  
7.
4 p, 26.6 KB Predisposició Genètica al Càncer [42929] / Surrallés i Calonge, Jordi (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Universitat Autònoma de Barcelona. Facultat de Biociències
The aim of this module is to dissect the genetic basis of cancer predisposition. We will discuss and perform laboratory experiments to explore the molecular basis of syndromes such as hereditary breast cancer, familiar colon cancer or rare DNA repair syndromes characterized by cancer predisposition such as Xeroderma pigmentosum, Fanconi anemia or Lynch syndromes. [...]
2015-16
Màster Universitari en Genètica Avançada / Advanced Genetics [1156]
3 documentos
8.
4 p, 28.1 KB Diagnòstic genètic molecular [101973] / Surrallés i Calonge, Jordi (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Universitat Autònoma de Barcelona. Facultat de Biociències
Els principals objectius d'aquesta assignatura són: Conèixer i poder descriure les principals tècniques d'anàlisi molecular emprades usualment en el diagnòstic genètic. Seleccionar amb sentit crític les tècniques diagnòstiques més adients en cada cas. [...]
2015-16
Grau en Genètica [833]  
9.
4 p, 104.1 KB Diagnòstic genètic molecular [101973] / Surrallés i Calonge, Jordi (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Universitat Autònoma de Barcelona. Facultat de Biociències
Els principals objectius d'aquesta assignatura són: Conèixer i poder descriure les principals tècniques d'anàlisi molecular emprades usualment en el diagnòstic genètic. Seleccionar amb sentit crític les tècniques diagnòstiques més adients en cada cas. [...]
2014-15
Grau en Genètica [833]  
10.
3 p, 96.7 KB Predisposició Genètica al Càncer [42929] / Surrallés i Calonge, Jordi (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Universitat Autònoma de Barcelona. Facultat de Biociències
The aim of this module is to dissect the genetic basis of cancer predisposition. We will discuss and perform laboratory experiments to explore the molecular basis of syndromes such as hereditary breast cancer, familiar colon cancer or rare DNA repair syndromes characterized by cancer predisposition such as Xeroderma pigmentosum, Fanconi anemia or Lynch syndromes. [...]
2014-15
Màster Universitari en Genètica Avançada / Advanced Genetics [1156]
3 documentos

Materiales académicos : Encontrados 26 registros   1 - 10siguientefinal  ir al registro:
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.